Our portfolio

TrianecT

TrianecT develops StrokePointer, a portable EEG device that detects stroke severity in ambulances. The technology combines brain activity measurement through a proprietary headset with AI to diagnose Large Vessel Occlusion (LVO) strokes. Detection of an LVO stroke in the ambulance will allow patients to be immediately transported to a stroke center for timely treatment, to drastically improve the patient outcomes.

Industry: Diagnostics, Medical Technology, Stroke

Want to get in contact about TrianecT?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Improving orthopedic diagnostics with advanced joint loading device and AI-based imaging technology.
Amplifying treatment of chronic autoimmune diseases.
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.
Improving orthopedic diagnostics with advanced joint loading device and AI-based imaging technology.
Amplifying treatment of chronic autoimmune diseases.
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.